New Biopharmaceutical Company Launched with Focus on Pain Medication

Article

NKTR-181 is currently under review with the FDA, with a Prescription Drug User Fee Act (PDUFA) target action expected in August 2019.

Nektar Therapeutics today announced the formation of Inheris Biopharma, Inc. A CNS-focused company, Inheris is a wholly-owned subsidiary of Nektar.1

Inheris will be responsible for launch preparation and commercialization for NKTR-181, a novel, first-in-class, investigational opioid molecule.1 Indicated for the treatment of moderate to severe chronic low back pain, the drug is designed to provide potent pain relief without high levels of euphoria that can lead to abuse and addiction.2

“The potential for a novel advance in the treatment of chronic pain is particularly important right now given the opioid abuse crisis in our country," said Jay Galeota, the new company’s President and Chief Executive Officer, in a prepared statement1.

NKTR-181 is currently under review with the FDA, with Prescription Drug User Fee Act target action expected in August 2019.1

"Inheris will lead all of the preparations for the potential commercialization of NKTR-181, as well as development of other CNS programs, enabling Nektar to remain focused on advancing our immuno-oncology and immunology development pipeline," said Howard W. Robin, President and CEO of Nektar, in a prepared statement.1

In addition to Galeota’s appointment, Nektar announced Dr Joe Stauffer as Chief Medical Officer of Inheris, and George Shiebler as the new company’s Senior Vice President & General Counsel. Inheris will be headquartered in northern New Jersey.1

References

  • Nektar Announces the Launch of Inheris Biopharma, Inc. [news release]. San Francisco, CA; May 23, 2019: Nektar Therapeutics. https://ir.nektar.com/news-releases/news-release-details/nektar-announces-launch-inheris-biopharma-inc. Accessed May 23, 2019.
  • Nektar. R & D Pipeline: NKTR-181. Nektar website. https://www.nektar.com/pipeline/rd-pipeline/nktr-181. Accessed May 23, 2019.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund | stock.adobe.com
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.